The Europe Pneumonia Vaccines Market would witness market growth of 4.5% CAGR during the forecast period (2019–2025).
Pneumococcal diseases are most common in younger children; however, adults and the elderly population are also prone to pneumococcal contaminations that lead to death as well. Pneumonia vaccines are primarily given to the children less than 2 years and to the adults of 65 years and older. These vaccines help to provide immunization against 13 types of pneumococcal bacteria that cause infection in the lungs. Increasing government support in creating awareness regarding pneumonia immunization programs, rising prevalence of pneumococcal contaminations within the population, and introduction of novel pneumococcal vaccines are some of the major factors driving the growth of the global pneumonia vaccine market. However, longer timelines required for the production of pneumococcal vaccines and higher costs associated with the development of the vaccines are hindering the growth of the market.
Based on Vaccine Type, the market is segmented into Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV). Based on Product Type, the market is segmented into Prevnar 13, Synflorix and Pneumovax23. According to sector, the market is segmented into Public sector and Private sector. Based on Distribution Channel, the market is further segmented into Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Glaxosmithkline Plc. (GSK), LG Corporation, Panacea Biotec Limited, Pfizer, Inc., Pnuvax Incorporated, Poonawalla Investments & Industries Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Holdings Co., Ltd., Walvax Biotechnology Co., Ltd. and MERCK & CO., Inc.
Scope of the Study
By Vaccine Type
• Pneumococcal conjugate vaccine (PCV)
• Pneumococcal polysaccharide vaccine (PPSV/PPV)
By Product Type
• Prevnar 13
• Public sector
• Private sector
By Distribution Channel
• Distribution partner companies
• Non-governmental Organizations (NGO)
• Government Authorities
• Rest of Europe
• Glaxosmithkline Plc. (GSK)
• LG Corporation
• Panacea Biotec Limited
• Pfizer, Inc.
• Pnuvax Incorporated
• Poonawalla Investments & Industries Pvt. Ltd.
• Shenzhen Kangtai Biological Products Co., Ltd.
• SK Holdings Co., Ltd.
• Walvax Biotechnology Co., Ltd.
• Merck & Co., Inc.
Our reports have been used by over 10K customers, including:
200 pages •
By The Business Research Company
• Jul 2020
Major players in the COVID19 vaccine and therapeutics pipeline analysis market are CanSino Biologics, Moderna, Inovio Pharmaceuticals, Regeneron, Gilead Sciences, GlaxoSmithKline, Medicago Inc., Sanofi, University of Oxford, and Altimmune. The COVID19 vaccine and therapeutics pipeline analysis market covered in this report is segmented...
Oral Vaccine Market Research Report by Type (Attenuated and Inactive), by Application (Cholera, HIV, Polio, Rabies, and Respiratory Infection), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Oral Vaccine Market is expected to grow from USD 13,349.49 Million in 2019 to USD 18,355.31...
Poliomyelitis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Poliomyelitis - Pipeline Review, H1 2020, provides an overview of the Poliomyelitis (Infectious Disease) pipeline landscape. Polio is a highly infectious disease caused by a virus....
Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H1 2020 Summary Hepatitis C Virus Envelope Protein E2 pipeline Target constitutes close to 9 molecules. Out of which approximately 3 molecules are developed by companies and remaining by the universities/institutes. The latest report Hepatitis...
Tuberculosis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis – Pipeline Review, H1 2020, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape. Tuberculosis, commonly known as TB, is a bacterial infection...
326 pages •
By Asia Market Information & Development Company
• May 2020
China’s demand for Vaccines has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and...
The Global Drug Delivery Partnering 2014-2020 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. This report provides details of the latest Drug Delivery agreements announced in the life sciences...
Rotavirus Infections - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Rotavirus Infections - Pipeline Review, H1 2020, provides an overview of the Rotavirus Infections (Infectious Disease) pipeline landscape. Rotavirus is a virus that infects...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.